WEKO3
アイテム
{"_buckets": {"deposit": "f07415b1-539f-4423-9d11-a4ba30a7ed29"}, "_deposit": {"created_by": 1, "id": "69526", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "69526"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00069526", "sets": ["28"]}, "author_link": ["682311", "682309", "682321", "682310", "682322", "682315", "682319", "682314", "682316", "682318", "682327", "682317", "682323", "682313", "682324", "682328", "682325", "682320", "682326", "682312"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2008-10-15", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Aim: Gastrointestinal stromal tumor (GIST) is a most common mesenchymal tumor arising from the human gastrointestinal tract. Overexpression of c-kit, encoding type III receptor tyrosine kinase, and its functional mutation is present in most GIST. 18F-fluoro-deoxyglucose (FDG) has been reported to highly accumulate in GISTs, and positron emission tomography using FDG (FDG-PET) is very useful for tumor detection and also for the assessment of early response to treatments using Imatinib (Gleevec). However, FDG-PET, in some cases, fails to detect relapse of GIST at early time point. If we could develop a specific method to detect c-kit expression, it can be used for the evaluation of the early response and relapse of GISTs. In this study, we labeled anti-c-kit antibodies with 125I and 111In, and assessed its in vitro and in vivo characteristics.\nMaterials \u0026 methods: We constructed an expressing vector of mutated c-kit and transfected it to HEK293 human embryonic kidney cells and isolated several stable clones. To select highly expressing cell clones, we determined c-kit expression using western blot analysis and immunofluorescent staining. The cell suspension (1x107) was mixed with Matrigel, and injected subcutaneously in BALB/c-nu/nu male mice. We radiolabeled two anti-c-kit murine monoclonal antibodies (Mab1 and Mab2) with 125I using the chloramine-T or 3\u0027-lodohippuryl-Ne-maleoyl-L-lysine (HML), and 111In using the 2-(p-isothiocyanatobenzyl) cyclohexyl-diethyl-enetriaminepentaacetic acid (CHX-A\"-DTPA). We performed cell binding, competitive inhibition and internalization assays in vitro, and biodistribution and SPECT imaging in tumor-bearing mice.\nResults: We isolated 18 c-kit stably expressing cell clones, and determined 6 of them highly express c-kit using western blotting analysis. Immunofluorescent staining of c-kit highly expressing cells showed that c-kit is primarily localized on the cell membrane like the original GIST cell line, and developed tumors in mice. 125I-MAb1, 125I-MAb1(HML), 125I-Mab2, 111In-MAb1 and 111In-MAb2 specifically bound to c-kit expressing cells with affinity constants of 4.3x108M-1, 5.2x108M-1, 3.5x108M-1, 3.4x108M-1 and 3.9x108M-1, respectively. These antibodies were internalized, and 111In-labeled Mab1 highly accumulated in xenografted tumors, which were visualized by SPECT.\nConclusion: These results showed that the radiolabeled c-kit antibody specifically accumulated in xenografted tumors and would be useful for the PET/SPECT imaging of GIST.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "Annual Congress of the European Association of Nuclear Medicine 2008", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Sogawa, Chizuru"}], "nameIdentifiers": [{"nameIdentifier": "682309", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Atsushi"}], "nameIdentifiers": [{"nameIdentifier": "682310", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugyou, Aya"}], "nameIdentifiers": [{"nameIdentifier": "682311", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sudou, Hitomi"}], "nameIdentifiers": [{"nameIdentifier": "682312", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okada, Keiichirou"}], "nameIdentifiers": [{"nameIdentifier": "682313", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Arano, Yasushi"}], "nameIdentifiers": [{"nameIdentifier": "682314", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Koizumi, Mitsuru"}], "nameIdentifiers": [{"nameIdentifier": "682315", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Furukawa, Takako"}], "nameIdentifiers": [{"nameIdentifier": "682316", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Harada, Yoshinobu"}], "nameIdentifiers": [{"nameIdentifier": "682317", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Saga, Tsuneo"}], "nameIdentifiers": [{"nameIdentifier": "682318", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "曽川 千鶴", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682319", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 厚至", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682320", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "須尭 綾", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682321", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "須藤 仁美", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682322", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 圭一郎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682323", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "荒野 泰", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682324", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小泉 満", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682325", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "古川 高子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682326", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "原田 良信", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682327", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "佐賀 恒夫", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "682328", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Development of anti c-kit monoclonal antibody probe for SPECT imaging of gastrointestinal stromal tumor", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Development of anti c-kit monoclonal antibody probe for SPECT imaging of gastrointestinal stromal tumor"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/69526", "pubdate": {"attribute_name": "公開日", "attribute_value": "2008-10-21"}, "publish_date": "2008-10-21", "publish_status": "0", "recid": "69526", "relation": {}, "relation_version_is_last": true, "title": ["Development of anti c-kit monoclonal antibody probe for SPECT imaging of gastrointestinal stromal tumor"], "weko_shared_id": -1}
Development of anti c-kit monoclonal antibody probe for SPECT imaging of gastrointestinal stromal tumor
https://repo.qst.go.jp/records/69526
https://repo.qst.go.jp/records/695267a6c5b46-8229-4bc4-b6a4-6e69426876c2
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-10-21 | |||||
タイトル | ||||||
タイトル | Development of anti c-kit monoclonal antibody probe for SPECT imaging of gastrointestinal stromal tumor | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Sogawa, Chizuru
× Sogawa, Chizuru× Tsuji, Atsushi× Sugyou, Aya× Sudou, Hitomi× Okada, Keiichirou× Arano, Yasushi× Koizumi, Mitsuru× Furukawa, Takako× Harada, Yoshinobu× Saga, Tsuneo× 曽川 千鶴× 辻 厚至× 須尭 綾× 須藤 仁美× 岡田 圭一郎× 荒野 泰× 小泉 満× 古川 高子× 原田 良信× 佐賀 恒夫 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Aim: Gastrointestinal stromal tumor (GIST) is a most common mesenchymal tumor arising from the human gastrointestinal tract. Overexpression of c-kit, encoding type III receptor tyrosine kinase, and its functional mutation is present in most GIST. 18F-fluoro-deoxyglucose (FDG) has been reported to highly accumulate in GISTs, and positron emission tomography using FDG (FDG-PET) is very useful for tumor detection and also for the assessment of early response to treatments using Imatinib (Gleevec). However, FDG-PET, in some cases, fails to detect relapse of GIST at early time point. If we could develop a specific method to detect c-kit expression, it can be used for the evaluation of the early response and relapse of GISTs. In this study, we labeled anti-c-kit antibodies with 125I and 111In, and assessed its in vitro and in vivo characteristics. Materials & methods: We constructed an expressing vector of mutated c-kit and transfected it to HEK293 human embryonic kidney cells and isolated several stable clones. To select highly expressing cell clones, we determined c-kit expression using western blot analysis and immunofluorescent staining. The cell suspension (1x107) was mixed with Matrigel, and injected subcutaneously in BALB/c-nu/nu male mice. We radiolabeled two anti-c-kit murine monoclonal antibodies (Mab1 and Mab2) with 125I using the chloramine-T or 3'-lodohippuryl-Ne-maleoyl-L-lysine (HML), and 111In using the 2-(p-isothiocyanatobenzyl) cyclohexyl-diethyl-enetriaminepentaacetic acid (CHX-A"-DTPA). We performed cell binding, competitive inhibition and internalization assays in vitro, and biodistribution and SPECT imaging in tumor-bearing mice. Results: We isolated 18 c-kit stably expressing cell clones, and determined 6 of them highly express c-kit using western blotting analysis. Immunofluorescent staining of c-kit highly expressing cells showed that c-kit is primarily localized on the cell membrane like the original GIST cell line, and developed tumors in mice. 125I-MAb1, 125I-MAb1(HML), 125I-Mab2, 111In-MAb1 and 111In-MAb2 specifically bound to c-kit expressing cells with affinity constants of 4.3x108M-1, 5.2x108M-1, 3.5x108M-1, 3.4x108M-1 and 3.9x108M-1, respectively. These antibodies were internalized, and 111In-labeled Mab1 highly accumulated in xenografted tumors, which were visualized by SPECT. Conclusion: These results showed that the radiolabeled c-kit antibody specifically accumulated in xenografted tumors and would be useful for the PET/SPECT imaging of GIST. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Annual Congress of the European Association of Nuclear Medicine 2008 | |||||
発表年月日 | ||||||
日付 | 2008-10-15 | |||||
日付タイプ | Issued |